Case Study of Two Post Vaccination SARS-CoV-2 Infections with P1 Variants in CoronaVac Vaccinees in Brazil

The rapid development of efficacious and safe vaccines against coronavirus disease 2019 (COVID-19) has been instrumental in mitigating the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Moreover, the emergence of SARS-CoV-2 variants raised concerns on the efficacy of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Estofolete, Cassia F., Banho, Cecilia A., Campos, Guilherme R. F., Marques, Beatriz de C., Sacchetto, Livia, Ullmann, Leila S., Possebon, Fabio S., Machado, Luana F., Syrio, Juliana D., Araújo Junior, João P., Bittar, Cintia, Rahal, Paula, Lobo, Suzana M. A., Ferreira, Helena Lage, Vasilakis, Nikos, Nogueira, Mauricio L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309964/
https://www.ncbi.nlm.nih.gov/pubmed/34206727
http://dx.doi.org/10.3390/v13071237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309964/
https://www.ncbi.nlm.nih.gov/pubmed/34206727
http://dx.doi.org/10.3390/v13071237

Ejemplares similares